Quanterix Corporation (QTRX)
NASDAQ • Healthcare
Last close at September 9, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q2 2026Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Nov 9
in 60 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
About Quanterix Corporation
Quanterix Corporation develops and sells digital immunoassay tools and related services for research and diagnostic work in healthcare, with its shares listed on the NASDAQ under QTRX. Its portfolio spans instruments, consumables, and lab services, and it generated $138.7 million of revenue in FY2025.
Today's Snapshot
So far today, QTRX is trading 4.3% lower at 2.54, while its sector was flat.
Trading Volume
Below 10d avg (477.8K)
211.9K
vs S&P 500 Today
Strong Underperformance
-3.78%
Updated: September 10, 2026 at 16:32 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$2.66 - $4.38Sell
- RSI (14)40.16Neutral
- Stochastic %K (14, 3, 3)26.78Neutral
- MACD Level (12, 26)-0.19Neutral
Peers & Related Assets
Get premium market insights delivered directly to your inbox.